In Australia, New Zealand, and Japan we leverage a strong network of strategic partners to ensure patients have access to biosimilar medicines while supporting a more sustainable healthcare system. We are expanding our presence in these markets, particularly by growing our

What would you tell your younger self if you had the chance? In this edition, Suman shares what she would offer her younger self. From trusting the path, even when it's unclear, to embracing every opportunity for growth, and believing in something far greater: saving lives. Stay

Research today shapes tomorrow's treatments for breast cancer patients.   Today, on Breast Cancer Research Day, we reflect on the critical role of scientific research in advancing oncology care and expanding treatment options for patients worldwide.   At Biocon Biologics, we

Introducing Biocon Biologics Across Europe! At Biocon Biologics, our mission is clear: every patient deserves access to life-changing treatments. That’s why we work closely with healthcare professionals and institutions across Europe to make biosimilars accessible to all who

This Psoriasis Awareness Month, we at Biocon Biologics reaffirm our commitment to supporting the millions of people living with psoriasis globally.   Psoriasis affects approximately 2-3% of the global population, yet many patients still face barriers to accessing effective

In the last few years, we’ve seen how biosimilars are enhancing access to life-improving treatments across many therapeutic areas such as diabetes, immunology, and oncology. For patients, this means having more treatment options that can improve quality of life and health

Biocon Biologics in Southern Europe! Our teams in Cyprus, Greece, Italy, Malta, Portugal, and Spain are dedicated to making healthcare systems more sustainable. In Italy, biosimilar adoption increased by 4.7% in 2023 alone. Additionally, biosimilars have helped drive €1.7

Biocon Biologics is proud to be a sponsor of the Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) National Conference in Las Vegas (Sept 4–6). The event brings together advanced practice providers who specialize in GI disorders and chronic liver disease for

We’re proud to have supported Evertreen in Europe in their mission to make the planet a better place by planting trees, reinforcing our commitment to environmental responsibility and community care. For Biocon Biologics, environmental health and human health are interconnected.

We were proud to participate in the 15th Biosimilars & Biologics Global Congress 2025 Europe in London, where industry leaders gathered to discuss the clinical future of biosimilars. The congress provided an invaluable platform for sharing insights on how constantly updated data

Annual Congress of the Swiss Society of Rheumatology Biocon Biologics was proud to participate in this year’s Swiss Society of Rheumatology Congress in Interlaken, contributing to the ongoing dialogue on innovation in rheumatology care. The event provided a valuable opportunity

Committed to Eye Care Expanding access to eye care treatments through biosimilars drives our work in ophthalmology, which is why we were pleased to attend the 25th Euretina Congress in Paris, September 4-7 at the Palais des Congrès. #EURETINA2025 brought together thousands of

At the 2025 Vizient Connections Summit, September 15–18 in Las Vegas, Biocon Biologics will join more than 4,000 healthcare leaders dedicated to exploring new ideas and approaches for the future of healthcare. The conference provides a valuable platform for sharing perspectives

We’re pleased to announce that with a new biosimilar approval from the U.S. Food and Drug Administration, Biocon Biologics is able to deliver innovative treatment options for osteoporosis and oncology care in the United States. This reflects our ongoing commitment to

Biocon Biologics: Advancing Access to Biosimilars Globally Biocon Biologics CEO & Managing Director, Shreehas Tambe, recently joined CNBC-TV18 ’s Bazaar Morning Call to reflect on the company’s progress over the past several months. In the last 10 months, Biocon Biologics

What does a career at Biocon Biologics really look like? Hear it straight from our team! In this new series, we share the lessons, leaps, and life-changing moments of many across Biocon Biologics, that make this more than just a workplace. Here's a look at Shruti Saxena,

Our teams in France, Belgium, Netherlands, and Luxembourg are dedicated to raising awareness of the essential role biosimilars play in building a more sustainable healthcare system. In France, we remain committed to expanding the availability of biosimilars. We firmly believe

We’re delighted to welcome  Ben Chen to Biocon Biologics as Global Head of Quality Assurance. Ben brings over 25 years of global experience across the U.S., Europe, and Asia, having held senior leadership roles in Quality functions at reputed global organizations. Ben has

Every new beginning comes with fresh perspectives and stories waiting to unfold. Meet Divya Parsekar, as she shares her first impressions of Biocon Biologics and what it feels like to start a purposeful journey with us.

Biocon Biologics was honored to participate in the German Rheumatology Congress 2025 in Wiesbaden, contributing to vital discussions on the future of rheumatological care in Germany. The congress brought together leading experts to address challenges in providing adequate